Lv5
1090 积分 2023-07-02 加入
Recalibrating Dual Checkpoint Blockade? Lessons from Volrustomig
24天前
已完结
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
2个月前
已完结
Target identification and assessment in the era of AI
2个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
3个月前
已完结
Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives
4个月前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
9个月前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
1年前
已完结
Recent advances in asthma mucus biology and emerging treatment strategies
1年前
已完结
Intramuscular Tranexamic Acid in Tactical and Combat Settings
1年前
已完结
皖公网安备34019202002308
